 CAMBRIDGE, Mass., Dec. 21, 2022 GLOBE NEWSWIRE -- Agios Pharmaceuticals, Inc. Nasdaq: AGIO, a leader in the field of cellular metabolism pioneering therapies for rare diseases, today announced that the company is scheduled to present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 7:30 a.m. PT. 